Synonyms: APG-1244 | BM-1244
Compound class:
Synthetic organic
Comment: APG-1252-M1 is the active metabolite of the prodrug pelcitoclax (APG-1252). It is a dual inhibitor of the apoptosis suppressor proteins Bcl-2 and Bcl-XL [2]. Structurally APG-1252 is a Bcl-2 BH3 homology domain mimetic that binds to both target proteins and disrupts their anti-apoptotic function. This action induces Bax-dependent cancer cell apoptosis. The prodrug is an active clinical candidate (Jan 2024).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
View the entry for APG-1252-M1 for quantitatice data for the bioactive metabolite at molecular targets. |
Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|